JS
JSM
NAVIENT CORP
$18.44
+0.77%
$1.8B
No data for this timeframe.
Vol
Market Cap$1.8B
Cap SizeSmall Cap
SEC Reports4
Exchange Nasdaq·Sector Security Brokers, Dealers & Flotation Companies·Inc. DE·CIK 0001593538·Prev Close $18.30
Recent Activity
May 29, 2026
SEC
Navient Corporation completed a $500,000,000 public offering of 9.375% Senior Notes due 2031, issued under an underwriti
8-K — Impact 4/10
May 26, 2026
SEC
Navient Corporation filed a preliminary prospectus supplement for an offering of senior unsecured notes due 2031, with t
424B5 — Impact 3/10
Apr 16, 2026
SEC
Navient Corporation filed a definitive proxy statement (DEFA14A) for its annual meeting, following recent leadership cha
DEFA14A — Impact 3/10
Analyst Ratings
0Strong Buy
1Buy
6Hold
4Sell
2Strong Sell
Latest Reports
NEUTRAL
8-K
4/10
Navient Corporation completed a $500,000,000 public offering of 9.375% Senior Notes due 2031, issued under an underwriti
May 29, 2026
NEUTRAL
424B5
3/10
Navient Corporation filed a preliminary prospectus supplement for an offering of senior unsecured notes due 2031, with t
May 26, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 3.3/10.
NEUTRAL
8-K
4/10
Navient Corporation completed a $500,000,000 public offering of 9.375% Senior Notes due 2031, issued
May 29, 2026
NEUTRAL
424B5
3/10
Navient Corporation filed a preliminary prospectus supplement for an offering of senior unsecured no
May 26, 2026
NEUTRAL
DEFA14A
3/10
Navient Corporation filed a definitive proxy statement (DEFA14A) for its annual meeting, following r
Apr 16, 2026
NEUTRAL
8-K
3/10
Navient announced a leadership transition with Board Chair Edward Bramson becoming CEO effective Jun
Apr 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 8% buy across 13 analysts — 0 strong buy, 1 buy, 6 hold, 4 sell, 2 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 1 | 6 | 4 | 2 | 8% | |
| May 1, 2026 | 0 | 1 | 6 | 4 | 2 | 8% | |
| Apr 1, 2026 | 0 | 1 | 7 | 4 | 2 | 7% | |
| Mar 1, 2026 | 0 | 1 | 7 | 4 | 2 | 7% | |
| Feb 1, 2026 | 0 | 1 | 7 | 4 | 2 | 7% | |
| Jan 1, 2026 | 0 | 1 | 7 | 4 | 2 | 7% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.